AR
Aparna Rajput
About Aparna Rajput
Data last updated:
Aparna Rajput has 6 years in corporate governance. Holds Director role. Currently with 3 companies, including Redvaxin Private Limited and Supritech Solutions Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The largest current company by reported revenue is Redvaxin Private Limited at ₹10.21 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 12 Jul 2020 | 2020 | ₹10.21 Cr (FY 2024) | Active | |
| Director | 17 Oct 2025 | 2025 | – | Active | |
| Director | 29 Jun 2024 | 2024 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Aparna Rajput
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aparna Rajput
Aparna Rajput has 6 years in corporate governance. Holds Director role. Currently with 3 companies, including Redvaxin Private Limited and Supritech Solutions Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The largest current company by reported revenue is Redvaxin Private Limited at ₹10.21 Cr (FY 2024).
Aparna Rajput is associated with 3 companies as Director, including Redvaxin Private Limited (₹10.21 Cr), Redvaxin (I) Private Limited, Supritech Solutions Private Limited.
Aparna Rajput has expertise in General Business, Technology.
Aparna Rajput has 6 years in corporate governance.
By reported revenue, the largest current company of Aparna Rajput is Redvaxin Private Limited, with revenue of ₹10.21 Cr (FY 2024).
Aparna Rajput currently holds positions at 3 companies: Redvaxin Private Limited (₹10.21 Cr), Redvaxin (I) Private Limited, Supritech Solutions Private Limited.